Rituximab for the treatment of refractory pediatric autoimmune diseases: a case series

INTRODUCTION: To report on efficacy, tolerability and safety of rituximab in children with refractory autoimmune diseases. CASE PRESENTATION: Five patients (juvenile dermatomyositis, Wegener's granulomatosis, systemic lupus erythematosus, myasthenia gravis and multiple sclerosis with systemic l...

Descripción completa

Detalles Bibliográficos
Autores principales: Tzaribachev, Nikolay, Koetter, Ina, Kuemmerle-Deschner, Jasmin B, Schedel, Joerg
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827140/
https://www.ncbi.nlm.nih.gov/pubmed/20184679
http://dx.doi.org/10.4076/1757-1626-2-6609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827140/
https://www.ncbi.nlm.nih.gov/pubmed/20184679
http://dx.doi.org/10.4076/1757-1626-2-6609

Ejemplares similares